21-hydroxylase deficiency other diagnostic studies: Difference between revisions
| Line 3: | Line 3: | ||
{{CMG}} {{AE}} {{AAM}} | {{CMG}} {{AE}} {{AAM}} | ||
==Overview== | ==Overview== | ||
There are no other additional diagnostic finding for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. | |||
==Other Diagnostic Studies== | ==Other Diagnostic Studies== | ||
Revision as of 16:38, 14 July 2017
|
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency Microchapters |
|
Differentiating Congenital adrenal hyperplasia due to 21-hydroxylase deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
21-hydroxylase deficiency other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of 21-hydroxylase deficiency other diagnostic studies |
|
21-hydroxylase deficiency other diagnostic studies in the news |
|
Directions to Hospitals Treating Congenital adrenal hyperplasia due to 21-hydroxylase deficiency |
|
Risk calculators and risk factors for 21-hydroxylase deficiency other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]
Overview
There are no other additional diagnostic finding for congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Other Diagnostic Studies
Immunohistochemical staining of the adrenal-gland may be used in patients with classic 21-hydroxylase deficiency and it demonstrates:[1]
- Poorly defined zonation
- Intermingling of the chromaffin and cortical cells
References
- ↑ https://en.wikipedia.org/wiki/Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency URL Accessed on 10/15/2015